Variant report

Variant	nsv885963
Chromosome Location	chr6:57932809-58144557
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:85)
CpG islands
(count:549)
Chromatin interactive
region (count:0)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:85 , 50 per page) page: 1 2

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF1	chr6:57996881-57996935	K562	blood:	n/a	n/a
2	ATF3	chr6:58141691-58142004	K562	blood:	n/a	n/a
3	ATF3	chr6:58142478-58142721	A549	lung:	n/a	n/a
4	ATF3	chr6:58142472-58142715	K562	blood:	n/a	n/a
5	CEBPB	chr6:58030489-58030521	HepG2	liver:	n/a	chr6:58030490-58030499 chr6:58030490-58030501 chr6:58030490-58030499 chr6:58030490-58030499 chr6:58030490-58030501 chr6:58030490-58030499
6	CTCF	chr6:57983763-57983815	GM20000	blood:	n/a	n/a
7	CTCF	chr6:58142480-58142630	HEK293	kidney:	n/a	n/a
8	CTCF	chr6:58077742-58077787	LNCaP	prostate:	n/a	n/a
9	CTCF	chr6:57964797-57964883	GM10248	blood:	n/a	n/a
10	CTCF	chr6:58032451-58032505	GM10266	blood:	n/a	n/a
11	CTCF	chr6:58060413-58060476	GM10248	blood:	n/a	n/a
12	CTCF	chr6:58032301-58032319	HepG2	liver:	n/a	n/a
13	CTCF	chr6:58073423-58073477	Fibrobl	skin:	n/a	n/a
14	CTCF	chr6:58074116-58074175	ProgFib	skin:	n/a	n/a
15	CTCF	chr6:57944165-57944201	Kidney_OC	kidney:	n/a	n/a
16	CTCF	chr6:58142224-58142294	MCF-7	breast:	n/a	n/a
17	CTCF	chr6:58021630-58021707	Medullo	brain:	n/a	n/a
18	CTCF	chr6:57976615-57976701	GM13977	blood:	n/a	n/a
19	CTCF	chr6:58142262-58142315	Fibrobl	skin:	n/a	n/a
20	CTCF	chr6:58082567-58082591	GM10248	blood:	n/a	n/a
21	CTCF	chr6:58047077-58047104	Lung_OC	lung:	n/a	n/a
22	CTCF	chr6:58025840-58025911	Medullo	brain:	n/a	n/a
23	CTCF	chr6:58081118-58081160	Medullo	brain:	n/a	n/a
24	CTCF	chr6:58078687-58078728	Kidney_OC	kidney:	n/a	n/a
25	CTCF	chr6:58060036-58060088	LNCaP	prostate:	n/a	n/a
26	CTCF	chr6:57981484-57981502	GM20000	blood:	n/a	n/a
27	CTCF	chr6:58071598-58071641	Spleen_OC	spleen:	n/a	n/a
28	E2F6	chr6:58142171-58142329	K562	blood:	n/a	n/a
29	ELF1	chr6:58142062-58142373	K562	blood:	n/a	chr6:58142291-58142300 chr6:58142290-58142301
30	EP300	chr6:58142613-58142720	GM12878	blood:	n/a	n/a
31	FOXA1	chr6:58020685-58020970	HepG2	liver:	n/a	n/a
32	FOXA1	chr6:57954173-57954464	HepG2	liver:	n/a	n/a
33	FOXA2	chr6:58020522-58021004	A549	lung:	n/a	n/a
34	FOXA2	chr6:57954002-57954518	A549	lung:	n/a	n/a
35	FOXP2	chr6:58142473-58142696	SK-N-MC	brain:	n/a	n/a
36	GATA2	chr6:58141776-58141849	SH-SY5Y	brain:	n/a	chr6:58141800-58141807 chr6:58141797-58141811 chr6:58141800-58141811 chr6:58141800-58141807 chr6:58141800-58141807
37	GATA2	chr6:58141804-58141806	HUVEC	blood vessel:	n/a	n/a
38	KAP1	chr6:58142581-58142663	U2OS	brain:	n/a	n/a
39	KAP1	chr6:58142595-58142625	HEK293	kidney:	n/a	n/a
40	KAP1	chr6:58141804-58141823	HEK293	kidney:	n/a	n/a
41	MAFK	chr6:58067217-58067297	HepG2	liver:	n/a	chr6:58067262-58067273 chr6:58067262-58067282
42	MAX	chr6:58142090-58142382	K562	blood:	n/a	n/a
43	MYC	chr6:58039420-58039444	MCF-7	breast:	n/a	n/a
44	MYC	chr6:58037654-58037687	Hela-S3	cervix:	n/a	n/a
45	MYC	chr6:58027285-58027385	MCF-7	breast:	n/a	n/a
46	POLR2A	chr6:57939757-57939785	MCF10A-Er-Src	breast:	n/a	n/a
47	POLR2A	chr6:58039345-58039456	A549	lung:	n/a	n/a
48	POLR2A	chr6:58027324-58027366	MCF-7	breast:	n/a	n/a
49	POLR2A	chr6:58027272-58027387	MCF-7	breast:	n/a	n/a
50	POLR2A	chr6:58027227-58027405	A549	lung:	n/a	n/a

(count:549 , 50 per page) page: 1 2 3 4 5 6 7 ... 11

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr6:58141890-58141940	HEEpiC	esophagus:	n/a
2	chr6:57972680-57972730	AG04449	skin:	fetal
3	chr6:57972680-57972730	IMR90	lung:	fetal
4	chr6:57970592-57970642	SK-N-SH	brain:	n/a
5	chr6:57972680-57972730	HCT-116	colon:	n/a
6	chr6:57972680-57972730	HCF	heart:	n/a
7	chr6:58141890-58141940	HIPEpiC	eye:	n/a
8	chr6:57972223-57972273	GM06990	blood:	n/a
9	chr6:58141890-58141940	A549	lung:	n/a
10	chr6:57972680-57972730	GM12878	blood:	n/a
11	chr6:58001971-58002021	GM12892	blood:	n/a
12	chr6:57972223-57972273	AG09319	gingival:	n/a
13	chr6:57972721-57972771	HUVEC	blood vessel:	n/a
14	chr6:57970592-57970642	SAEC	small airway:	n/a
15	chr6:57972721-57972771	AG04449	skin:	fetal
16	chr6:58141890-58141940	ECC-1	luminal epithelium:	n/a
17	chr6:57972223-57972273	HCM	heart:	n/a
18	chr6:57972721-57972771	AG09319	gingival:	n/a
19	chr6:58141890-58141940	HRPEpiC	eye:	n/a
20	chr6:57970592-57970642	PrEC	prostate:	n/a
21	chr6:57972721-57972771	BJ	skin:	n/a
22	chr6:57970592-57970642	SKMC	muscle:	n/a
23	chr6:57972349-57972399	HEEpiC	esophagus:	n/a
24	chr6:57970592-57970642	LNCaP	prostate:	n/a
25	chr6:57972721-57972771	U87	brain:	n/a
26	chr6:57970666-57970716	Jurkat	blood:	n/a
27	chr6:57972680-57972730	HEK293	kidney:	embryo
28	chr6:58001971-58002021	HRE	kidney:	n/a
29	chr6:57970592-57970642	HL-60	blood:	n/a
30	chr6:57972721-57972771	NB4	blood:	n/a
31	chr6:57972349-57972399	Hepatocyte	liver:	n/a
32	chr6:57972223-57972273	AG04450	lung:	fetal
33	chr6:58001971-58002021	SKMC	muscle:	n/a
34	chr6:57972680-57972730	NHBE	bronchial:	n/a
35	chr6:57972223-57972273	K562	blood:	n/a
36	chr6:57972223-57972273	PFSK-1	brain:	n/a
37	chr6:57972680-57972730	PFSK-1	brain:	n/a
38	chr6:57972223-57972273	U87	brain:	n/a
39	chr6:57970666-57970716	HAEpiC	amniotic membrane:	n/a
40	chr6:57972349-57972399	HCM	heart:	n/a
41	chr6:57970592-57970642	K562	blood:	n/a
42	chr6:57972721-57972771	GM12891	blood:	n/a
43	chr6:57970666-57970716	HL-60	blood:	n/a
44	chr6:58141890-58141940	ovcar-3	ovarian:	n/a
45	chr6:57970592-57970642	HPAEpiC	pulmonary alveolar:	n/a
46	chr6:57972349-57972399	SK-N-MC	brain:	n/a
47	chr6:58001971-58002021	ovcar-3	ovarian:	n/a
48	chr6:58001971-58002021	GM12878	blood:	n/a
49	chr6:58142044-58142094	NB4	blood:	n/a
50	chr6:58142044-58142094	GM12891	blood:	n/a

No data

Variant related genes	Relation type
ENSG00000270213	TF binding region
ENSG00000270213	CpG island

Extended variants
information (count: 199 )
Associated
traits (count: 68 )

Variant overlapped rSNPs/rCNVs (count:199 , 50 per page) page: 1 2 3 4

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs116610593	chr6:57944410-57944411	Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs532410669	chr6:57944411-57944412	Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs533393409	chr6:57944447-57944448	Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs551559732	chr6:57944522-57944523	Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs552495801	chr6:57944525-57944526	Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs183099334	chr6:57944573-57944574	Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs187560723	chr6:57944689-57944690	Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs150756983	chr6:57944708-57944709	Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs567992111	chr6:57944732-57944733	Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs192519406	chr6:58028452-58028453	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs552034748	chr6:58028464-58028465	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs145289168	chr6:58028465-58028466	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs573918108	chr6:58028468-58028469	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs372662490	chr6:58028479-58028480	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs534182244	chr6:58028482-58028483	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs147632909	chr6:58028492-58028493	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs555950413	chr6:58028496-58028497	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs574142309	chr6:58028503-58028504	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs538341849	chr6:58028519-58028520	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs184878482	chr6:58028540-58028541	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs368235801	chr6:58028543-58028544	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs4127223	chr6:58030496-58030497	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs536152964	chr6:58032311-58032312	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs538541212	chr6:58032480-58032481	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs575005295	chr6:58141208-58141209	Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs535692690	chr6:58141224-58141225	Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs557199258	chr6:58141245-58141246	Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs183776776	chr6:58141273-58141274	Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs111445126	chr6:58141352-58141353	Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs545789051	chr6:58141357-58141358	Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs112304630	chr6:58141368-58141369	Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs112370365	chr6:58141372-58141373	Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs564180201	chr6:58141378-58141379	Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs62412337	chr6:58141427-58141428	Bivalent/Poised TSS Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
35	rs375446090	chr6:58141436-58141437	Bivalent/Poised TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs540747109	chr6:58141440-58141441	Bivalent/Poised TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs368627485	chr6:58141449-58141450	Bivalent/Poised TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs186965648	chr6:58141463-58141464	Bivalent/Poised TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs367555793	chr6:58141485-58141486	Bivalent/Poised TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs370276998	chr6:58141516-58141517	Bivalent/Poised TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs562062052	chr6:58141542-58141543	Bivalent/Poised TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs529862280	chr6:58141553-58141554	Bivalent/Poised TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs541671098	chr6:58141569-58141570	Bivalent/Poised TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs563530158	chr6:58141573-58141574	Bivalent/Poised TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs373644013	chr6:58141590-58141591	Bivalent/Poised TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs552195297	chr6:58141662-58141663	Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
47	rs548179871	chr6:58141670-58141671	Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
48	rs528153281	chr6:58141744-58141745	Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
49	rs546647530	chr6:58141762-58141763	Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs568079323	chr6:58141766-58141767	Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:68)

Disease	PMID	Source
Leukemia	21518781	CNVD
Cancer	21637783	CNVD
Facial dysmorphism	22105932	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	21080181	CNVD
Hepatocellular carcinoma	22174799	CNVD
Endometrial cancer	22040021	CNVD
Acute myeloid leukemia	16864856	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Bladder cancer	19088036	CNVD
Wilms tumour	21544195	CNVD
Uveal melanoma	21693616	CNVD
Biliary cancer	19435499	CNVD
Malaria	21533027	CNVD
Retinoblastoma	19183342	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Ewing''s sarcoma	17952124	CNVD
Autism	21448237	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Autism	22495311	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Gastric cancer	17908304	CNVD
Neuroblastoma	16790693	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Neuroblastoma	18923191	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	17603634	CNVD
Systemic lupus erythematosus	17503323	CNVD
Gastrointestinal stromal cancer	20818650	CNVD
Breast cancer	16608533	CNVD
Melanoma	18172304	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Glioblastoma multiforme	22286061	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Colorectal cancer	16272173	CNVD
Breast cancer	21364760	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	17443227	CNVD
T-cell lymphomas	19863542	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Myelofibrosis	22110671	CNVD
small cell lung cancer	20016488	CNVD
Ovarian cancer	21720365	CNVD
Schizophrenia	20967226	CNVD
Lung cancer	18438408	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD

Chromatin state (count:63 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:57944400-57944800	Enhancers	Fetal Brain Male	brain
2	chr6:58141200-58141600	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
3	chr6:58141400-58141800	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
4	chr6:58141400-58143200	Bivalent/Poised TSS	HUES6 Cell Line	embryonic stem cell
5	chr6:58141400-58143400	Bivalent/Poised TSS	HUES48 Cell Line	embryonic stem cell
6	chr6:58141600-58141800	Bivalent Enhancer	IMR90 fetal lung fibroblasts Cell Line	lung
7	chr6:58141600-58141800	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin02	Skin
8	chr6:58141600-58141800	Bivalent Enhancer	Brain Germinal Matrix	brain
9	chr6:58141600-58141800	Bivalent Enhancer	Placenta	Placenta
10	chr6:58141600-58141800	Bivalent Enhancer	NHDF-Ad	bronchial
11	chr6:58141600-58142000	Bivalent Enhancer	HUVEC	blood vessel
12	chr6:58141600-58142000	Active TSS	K562	blood
13	chr6:58141600-58142200	Bivalent/Poised TSS	ES-WA7 Cell Line	embryonic stem cell
14	chr6:58141600-58142200	Bivalent/Poised TSS	Brain Dorsolateral Prefrontal Cortex	brain
15	chr6:58141600-58142200	Bivalent Enhancer	Fetal Muscle Leg	muscle
16	chr6:58141600-58142400	Active TSS	H1 Cell Line	embryonic stem cell
17	chr6:58141600-58143000	Active TSS	ES-I3 Cell Line	embryonic stem cell
18	chr6:58141600-58143000	Active TSS	H9 Cell Line	embryonic stem cell
19	chr6:58141600-58143000	Bivalent/Poised TSS	iPS-18 Cell Line	embryonic stem cell
20	chr6:58141600-58143000	Active TSS	ES-UCSF4 Cell Line	embryonic stem cell
21	chr6:58141600-58143000	Active TSS	Foreskin Fibroblast Primary Cells skin01	Skin
22	chr6:58141600-58143200	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
23	chr6:58141600-58143400	Bivalent/Poised TSS	iPS-20b Cell Line	embryonic stem cell
24	chr6:58141800-58142000	Flanking Bivalent TSS/Enh	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
25	chr6:58141800-58142000	Flanking Bivalent TSS/Enh	Cortex derived primary cultured neurospheres	brain
26	chr6:58141800-58142000	Bivalent/Poised TSS	Ganglion Eminence derived primary cultured neurospheres	brain
27	chr6:58141800-58142000	Flanking Bivalent TSS/Enh	Foreskin Fibroblast Primary Cells skin02	Skin
28	chr6:58141800-58142000	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin01	Skin
29	chr6:58141800-58142000	Flanking Bivalent TSS/Enh	Brain Hippocampus Middle	brain
30	chr6:58141800-58142000	Bivalent Enhancer	Fetal Stomach	stomach
31	chr6:58141800-58142000	Bivalent Enhancer	Fetal Thymus	thymus
32	chr6:58141800-58142000	Flanking Bivalent TSS/Enh	NHDF-Ad	bronchial
33	chr6:58141800-58142000	Bivalent Enhancer	NHEK	skin
34	chr6:58141800-58142200	Bivalent/Poised TSS	IMR90 fetal lung fibroblasts Cell Line	lung
35	chr6:58141800-58142200	Bivalent Enhancer	Breast Myoepithelial Primary Cells	Breast
36	chr6:58141800-58142200	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
37	chr6:58141800-58142200	Bivalent Enhancer	Primary T helper cells fromperipheralblood	blood
38	chr6:58141800-58142200	Flanking Bivalent TSS/Enh	Foreskin Melanocyte Primary Cells skin03	Skin
39	chr6:58141800-58142200	Bivalent Enhancer	Adipose Nuclei	Adipose
40	chr6:58141800-58142200	Flanking Bivalent TSS/Enh	Brain Germinal Matrix	brain
41	chr6:58141800-58142200	Bivalent Enhancer	Esophagus	oesophagus
42	chr6:58141800-58142200	ZNF genes & repeats	Right Atrium	heart
43	chr6:58141800-58142400	Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell
44	chr6:58141800-58142600	Bivalent/Poised TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
45	chr6:58141800-58142600	Enhancers	Pancreas	Pancrea
46	chr6:58141800-58143000	Active TSS	iPS-15b Cell Line	embryonic stem cell
47	chr6:58142000-58142200	Bivalent Enhancer	H9 Derived Neuron Cultured Cells	ES cell derived
48	chr6:58142000-58142200	Bivalent/Poised TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
49	chr6:58142000-58142200	Bivalent/Poised TSS	Foreskin Fibroblast Primary Cells skin02	Skin
50	chr6:58142000-58142200	Flanking Bivalent TSS/Enh	Foreskin Keratinocyte Primary Cells skin02	Skin

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links